- Staat
- MI
- Alter
- 23,0
- Geschlecht
- U
- Eingang
- 27.07.2022
- Impfdatum
- 17.05.2022
- Beginn
- 17.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Agitation
Anger
Anxiety
Seizure
Symptomtext
Patient had a seizure about an hour after receiving these vaccines. He had another seizure 2 days later. Patient was put on levETIRAcetam 500 mg orally twice daily (started on 5/20/2022 after 2nd seizure). Patient was taken off levETIRAcetam on 7/22/2022 due to increase in agitation, anxiety, and bad temper. He was put on Sertraline 50 mg. He is awaiting appointment with Neurology, which is scheduled for 9/9/2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure
- Hospital-Tage
- -
- Labordaten
- Awaiting EEG with Neuro Epilepsy on 08/31/2022.
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- Asthma
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 21.06.2022
- Impfdatum
- 21.06.2022
- Beginn
- 21.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Syncope
Symptomtext
Pt fainted after vaccination, upon assessment patient was conscious and responsive. we monitored oxygen levels, blood pressure, and breathing for approximately 30 minutes while patient was laying down and recovering. Patient was able to achieve normal vital signs by the end of 30 minutes and was observed getting into the vehicle safely. Instructed parent of child to be seen immediately at Urgent Care or Emergency Room for further evaluation and to rule out any injuries from fainting.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 15,0
- Geschlecht
- M
- Eingang
- 04.04.2022
- Impfdatum
- 30.03.2022
- Beginn
- 30.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Fall
Head injury
Neurological examination
Syncope
Symptomtext
A few minutes after receiving vaccines, approx 8:10pm, the pt fainted and fell in the exam room. The fall was witnessed by the pt's aunt. Per pt's aunt, the pt "got up from the table, fainted, fell and hit his head on the floor." When the nurse arrived to the room, the pt was laying on the floor with the aunt rubbing his head. Pt opened his eyes. The doctor was immediately called to the room and vital signs were taken. Pt denied pain and dizziness. Pt slowly got up from the floor and was able to sit on the table. Pt denied nausea, dizziness, and pain. The doctor assessed the pt and completed a neuro exam. The doctor advised the aunt to take the pt to the ER if pt c/o h/a, n/v, blurry vision. Pt stayed in waiting area for observation before leaving. Upon leaving, pt states he is feeling better. He continues to deny pain, dizziness, and nausea.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None reported.
- Vorgeschichte
- None reported.
- Andere Medikamente
- NA
- Allergien
- No known allergies.
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 11,0
- Geschlecht
- F
- Eingang
- 26.03.2022
- Impfdatum
- 10.03.2022
- Beginn
- 10.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Fall
Head injury
Loss of consciousness
Syncope
Symptomtext
Brief syncopal event fell and hit head, immediately regained consciousness, episode was about 1 minute long patient was lying flat on the ground when she regained consciousness
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- Multivitamin
- Allergien
- N.K.D.A
- Vorherige Impfungen
- -
- Staat
- ID
- Alter
- 14,0
- Geschlecht
- F
- Eingang
- 23.03.2022
- Impfdatum
- 23.03.2022
- Beginn
- 23.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Blindness
Presyncope
Symptomtext
Patient given Gardasil9 vaccine. Patient reported feeling and doing fine to medical staff, and appeared fine during reception checkout. Patient then experienced a vasovagal response in their personal vehicle (with mom present). Mom and/or patient reported that she lost her vision. Mom proceeded to call EMS from her personal vehicle in our parking lot. Patient was alert and talking to medical staff from our facility, as well as texting on her phone, prior to EMS response team arriving. Response team evaluated the patient and were done and leaving within 5 minutes of arriving. Patient and mom left momentarily afterward.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Presyncope
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- Pityriasis capitis
- Vorgeschichte
- Pityriasis capitis
- Andere Medikamente
- Vitamin C, Vitamin D
- Allergien
- Amoxicillin, Cat Dander, Penicillin
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 24.02.2022
- Impfdatum
- 23.02.2022
- Beginn
- 23.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Feeling hot
Malaise
Syncope
Vomiting
Symptomtext
Patient received vaccine and was advised to wait 10 minutes after appointment to monitor for adverse reaction. The patient exited the room with mother to go to the bathroom because he was not feeling well. Patient fainted without hitting his head while in the bathroom. Mother caught the patient in the fall. He proceeded to regain consciousness and vomited. Doctor assessed immediately and ensured he was okay before leaving. Following incident, mother stated this happens when he gets too warm. It was a warmer day and was warmer than usual in the office.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Anxiety
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 22.02.2022
- Impfdatum
- 22.02.2022
- Beginn
- 22.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Extremity contracture
Grunting
Hyperhidrosis
Loss of consciousness
Pallor
Vomiting
Symptomtext
Vaccinated while laying on table and waited a few minutes after vaccination to move into chair next to mom. Client then became light headed, pale, and dizzy with 15-20 second loss of consciousness with head on mom's shoulder while mom held her. Client grunted with a breath and arms contracted for a couple seconds. Client came to and was sweaty and vomited once. Elevated feet and water given.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- -
- Geschlecht
- F
- Eingang
- 08.05.2023
- Impfdatum
- 29.03.2022
- Beginn
- 17.03.2023
- Tage bis Beginn
- 353,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Injection site erythema
Injection site pain
Injection site reaction
Injection site swelling
Vaccination site erythema
Vaccination site pain
Vaccination site swelling
Symptomtext
The received the first dose on 3/29/2022 (lot u008315 8/15/2023) and second dose on 3/17/2023 (lot w013165 12/14/2024).; injection site reaction consisted of redness and swollen; injection site reaction consisted of redness and swollen; injection site reaction tender to the touch; This spontaneous report was received from a medical assistant and referred to a 42-year-old non-pregnant female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant medications included colecalciferol (VITAMINE D), birth control pills, inhalers and iron supplement. On 29-MAR-2022, the patient was vaccinated with first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection (0.5 milliliter, lot #U008315, expiration date: 15-AUG-2023, strength, anatomical location and route of administration were not provided) administered for prophylaxis. On 17-MAR-2023, the patient was vaccinated with second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection (0.5 milliliter, lot #w013165, expiration date: 14-DEC-2024, strength, anatomical location and route of administration were not provided) administered for prophylaxis (Inappropriate schedule of product administration). On an unknown date in 2023 (after receiving the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9)), the patient experienced injection site reaction consisted of redness and swollen (Vaccination site swelling; Vaccination site erythema), it was also tender to the touch (Vaccination site pain). At the time of reporting, the outcome of events vaccination site swelling, vaccination site erythema and vaccination site pain was recovering. The causal relationship between all events and hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) was not provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- VITAMINE D
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- -
- Geschlecht
- F
- Eingang
- 05.08.2022
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site pain
Vaccination site erythema
Vaccination site mass
Vaccination site swelling
Vaccination site warmth
Symptomtext
Vaccination site lump; Vaccination site redness; Vaccination site warmth; Vaccination site swelling; mild soreness at the injection site; mild soreness at the injection site; mild soreness at the injection site; This spontaneous report was received from a registered nurse, concerning a 36-year-old female patient. The patient's pertinent medical history included skin cancer diagnosed in 2012. The patient did not have any concomitant medications and drug reactions or allergies. On 10-DEC-2021, the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) pre-filled syringe, in the left deltoid, at a dose of 0.5 milliliter (ml) by intramuscular route (lot number U008315, which was verified to be a valid lot number, expiration date reported and upon internal validation established as 15-AUG-2023), indication reported as "human papillomavirus (HPV) vaccine". Subsequently, she experienced mild soreness at the injection site that lasted a few days and then went away (vaccination site pain). On 25-FEB-2022 and 16-JUN-2022, she was vaccinated with the second and third dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) pre-filled syringe, in the left deltoid, at a dose of 0.5 milliliter (ml) by intramuscular route (lot numbers U032636 and U029623, which were verified to be valid lot numbers, expiration dates not reported but upon internal validation established as 26-OCT-2023). The reporter further stated, the patient developed new onset of mild soreness at the injection site that lasted a few days and then went away (vaccination site pain) on unspecified dates in 2022 reported as "after the second and third dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9)". On 03-JUL-2022 reported as "approximately 2 weeks after the third dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9)", the patient experienced redness, warmth and swelling with a lump at the injection site (vaccination site erythema, vaccination site warmth, vaccination site swelling and vaccination site mass). The patient was advised to use cold compress. However, she contacted physician on 05-JUL-2022, as there was no improvement, she was still experiencing redness and swelling. At the time of the report, the outcome of the events vaccination site erythema, vaccination site warmth, vaccination site swelling and vaccination site mass was reported as not resolved. Causality assessment was not provided by the reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Skin cancer
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 15.04.2022
- Impfdatum
- 15.04.2022
- Beginn
- 15.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Nausea
Unresponsive to stimuli
Symptomtext
Client received 3 vaccines today. After 3rd vaccine administered, HPV, the client's eyes started closing an she began to tilt her head back. Client did not respond to verbal stimuli. Unresponsiveness lasted for less than a minute. Client later began feeling nauseous. Symptoms resolved by the time the client left the clinic.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Nausea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None reported
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 14,0
- Geschlecht
- F
- Eingang
- 30.03.2022
- Impfdatum
- 29.03.2022
- Beginn
- 29.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Flushing
Pallor
Symptomtext
Only HPV second dose administer, flushed, light headed and pale, had juice started to feel better after about 5 minutes. Safely left the office with mother
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 21,0
- Geschlecht
- F
- Eingang
- 18.01.2022
- Impfdatum
- 04.01.2022
- Beginn
- 11.01.2022
- Tage bis Beginn
- 7,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site pain
Pain in extremity
Symptomtext
Continued arm pain and soreness at injection site 2 weeks following injection,
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- -
- Andere Medikamente
- Spironolactone
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 31.03.2023
- Impfdatum
- 27.03.2023
- Beginn
- 30.03.2023
- Tage bis Beginn
- 3,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Skin warm
Symptomtext
redness, warmth
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Erythema
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- OSA, ADHD, GERD, chronic rhinitis
- Andere Medikamente
- atoMOXetine (STRATTERA) 60 mg capsule daily
- Allergien
- Amoxicillin, cefdinir, sulfa drugs
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 28.09.2022
- Impfdatum
- 01.09.2022
- Beginn
- 01.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
Patient is 12 years old and received Dtap. Should have received Tdap
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 13.06.2022
- Impfdatum
- 13.06.2022
- Beginn
- 13.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Aphasia
Pallor
Sleep deficit
Unresponsive to stimuli
Vision blurred
Symptomtext
Client presented to clinic for seventh grade vaccinations on 6/13/2022. At 11:40AM, client received vaccines listed above. Twenty seconds after completing vaccine administration, client stopped talking mid-sentence and leaned against cushion of exam table. Eyes staring ahead unfocused, client not responsive to verbal stimuli. After four seconds, client spontaneously sat up, becomes awake and alert x 4, and commented "I must have fell asleep for a moment" then continued with conversation. Lip color pale (client skin color very fair as baseline). Mother stated client has never passed out to vaccines before. Mother stated client admitted not have breakfast before coming. Client also stated attended camp all week the week before and "still sleep deprived." Mother stated family history of father passing out routinely for vaccines and blood draws. Gave water and Goldfish crackers, able to tolerate. After five minutes, client stated felt good to go. Escorted out to private vehicle by mother.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Aphasia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- -
- Geschlecht
- U
- Eingang
- 11.03.2022
- Impfdatum
- 27.01.2022
- Beginn
- 27.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No other AE; A dose was administered to a patient after a temperature excursion; This spontaneous report has been received from a nurse prescriber referring to a patient of unspecified age and gender. The patient's pertinent medical history, concomitant medications, concurrent conditions and previous drug reactions or allergies were not reported. On 27-JAN-2022, the patient was vaccinated with an improperly stored dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) 1 dose (route of administration, anatomical site of vaccination, and vaccine scheme were not reported; lot number U008315 has been verified to be valid, expiration date reported and established as 15-AUG-2023) for prophylaxis. The vaccine was exposed to a temperature excursion of 0.5 degrees Celsius (C) during a time frame of 168 hours (product storage error). There was no previous temperature excursion, and no other adverse event was reported (no adverse event). This is one of several reports received from the same reporter. ; Sender's Comments: US-009507513-2202USA003842: US-009507513-2202USA003879: US-009507513-2202USA003908: US-009507513-2202USA003856:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 17,0
- Geschlecht
- M
- Eingang
- 09.03.2022
- Impfdatum
- 09.03.2022
- Beginn
- 09.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Symptomtext
Medical assistant accidentally gave a extra dose of HPV
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- Bactrim
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- -
- Geschlecht
- U
- Eingang
- 21.02.2022
- Impfdatum
- 25.01.2022
- Beginn
- 25.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No adverse event; The caller said a dose was administered to a patient after a temperature excursion occurred.; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 25-JAN-2022, the patient was vaccinated with a dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) pre-filled syringe, 1 dose, lot #U008315, expiration date: 15-AUG-2023, administered for prophylaxis (strength, and route of administration were not provided) after a temperature excursion occurred. The vaccine underwent a temperature excursion of 0.5 degree Celsius (C) for a period of 168 hours (product storage error). The vaccine did not undergo previous temperature excursion. The patient did not experience any adverse event.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- -
- Geschlecht
- U
- Eingang
- 19.02.2022
- Impfdatum
- 31.01.2022
- Beginn
- 24.01.2022
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No other AE; A dose was administered to a patient after a temperature excursion; This spontaneous report was received from nurse practitioner and refers to a patient on unknown age or gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unspecified date, the vaccine was under temperature excursion with a temperature of 0.5?C for 168 hours. Previous to this, there was no temperature excursion. On 24-JAN-2022, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, 1 dose administered for prophylaxis (strength, and route of administration were not provided; lot #U008315 with an expiration date of 15-AUG-2023). No adverse events were reported.; Sender's Comments: US-009507513-2202USA003842: US-009507513-2202USA003818:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- -
- Geschlecht
- U
- Eingang
- 17.02.2022
- Impfdatum
- 31.01.2022
- Beginn
- 31.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
No Adverse event; a dose was administered to a patient after a temperature excursion occurred; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 31-JAN-2022, the patient was vaccinated with a dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) pre-filled syringe, 1 dose, lot #U008315, expiration date: 15-AUG-2023, administered for prophylaxis (strength, and route of administration were not provided) after a temperature excursion occurred. The vaccine underwent a temperature excursion of 0.5 degree Celsius (C) for a period of 168 hours. The vaccine did not undergo previous temperature excursion. The patient did not experience any adverse event.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- -
- Geschlecht
- F
- Eingang
- 04.02.2022
- Impfdatum
- -
- Beginn
- 13.01.2022
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administration interrupted
Symptomtext
Defective gardasil 9 syringe. The finger flanges were found to be broken; CALLER ST ATES IT WAS RECEIVED WRAPPED IN BUBBLE WRAP IN A PLASTIC BAG, THERE WAS NOT A TRAY / NO CARTON; Cut themself while handling Gardasil 9; Cut themself while handling Gardasil 9; This spontaneous report was received from the office manager concerning a female patient of unknown age. The patient's concurrent conditions, medical history, and concomitant therapies were not reported. On 13-JAN-2022, the finger flanges (all the way around) of a defective hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) syringe (lot # U008315, expiration date reported as 14-AUG-2023, but upon internal validation stablished as 15-AUG-2023) were found to be broken when the nurse practitioner was going to attach the needle to the syringe. The product was received wrapped in bubble wrap in a plastic bag, there was not a tray and no carton. An unknown staff member at the facility cut herself while handling the hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) with the broken flange. The product was not administered to a patient. The outcome of the wound was not reported. The causality assessment was not reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administration interrupted
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- -
- Geschlecht
- U
- Eingang
- 17.11.2021
- Impfdatum
- 03.11.2021
- Beginn
- 03.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No other issues or concerns reported; GARDASIL 9 that was administered/Temperature: 72F; This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 03-NOV-2021, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9), lot # U008315, expiry date 15-AUG-2023, for prophylaxis (route and location of administration were not reported), which was stored in a temperature of 72 degrees Fahrenheit for 120 hours (product storage error). No previous excursion was reported. The nurse inquired about stability of administered hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9). No other issues or concerns were reported (no adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -